ArticleThe Journal of allergy and clinical immunology2025

Psoriasis harbors multiple pathogenic type 17 T-cell subsets: Selective modulation by risankizumab.

Jaehwan Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.